A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study
Condition(s):Pyschotic DisordersLast Updated:February 21, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Pyschotic DisordersLast Updated:February 21, 2021Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:February 21, 2021Completed
Condition(s):Schizophreniform Disorder; Schizoaffective Disorder; Psychosis; Depressive Disorder, Major; Bipolar DisorderLast Updated:January 13, 2017Completed
Condition(s):Bipolar Disorder; Depression, BipolarLast Updated:March 10, 2021Completed
Condition(s):Bipolar DisorderLast Updated:February 21, 2021Withdrawn
Condition(s):Hyperglycemia; HyperlipidemiaLast Updated:July 18, 2018Completed
Condition(s):Depression, BipolarLast Updated:December 16, 2015Completed
Condition(s):Bipolar Mania; Bipolar DisorderLast Updated:March 25, 2021Completed
Condition(s):Social Anxiety DisorderLast Updated:October 31, 2014Completed
Condition(s):SchizophreniaLast Updated:September 10, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.